appleluxurycar.com

Effect of AF, olaparib and aurola treatment on immune-related

By A Mystery Man Writer

Aurora-A/SOX8/FOXK1 signaling axis promotes chemoresistance via suppression of cell senescence and induction of glucose metabolism in ovarian cancer organoids and cells

Elly MARCQ, Postdoctoral Researcher, Doctor of Medicine

PDF) Auranofin Synergizes with the PARP Inhibitor Olaparib to

Full article: Current Molecular and Clinical Landscape of ATRT – The Link to Future Therapies

Evelien SMITS, Full Professor, PhD

The summary of proteomic results of the R2780 cells treated with

Filip LARDON Full professor & Head research lab Center for

PARP inhibitor resistance in ovarian cancer: Underlying mechanisms and therapeutic approaches targeting the ATR/CHK1 pathway - ScienceDirect

Immunotherapeutic approaches for small-cell lung cancer

Jinthe VAN LOENHOUT, PhD Student

Christophe DEBEN, PostDoc Position, PhD

Effect of AF, olaparib and aurola treatment on immune-related

Antitumor effect of a WEE1 inhibitor and potentiation of olaparib sensitivity by DNA damage response modulation in triple-negative breast cancer. - Abstract - Europe PMC

Immunogenicity and efficacy of pembrolizumab and doxorubicin in a phase I trial for patients with metastatic triple-negative breast cancer